Needles being inserted into a patient's forearm. The<unk>  () were a series of nationwide<unk><unk>  set up in 2001 and published in 2006 on behalf of several<unk>  statutory health insurance companies because of a dispute as to the usefulness of<unk> . They consisted of one observational study on<unk>  side effects, and four randomized controlled<unk>  (RCTs) investigating<unk>  treatment for low back pain, knee osteoarthritis, migraine prophylaxis, and tension-type headache. The<unk>  are considered to be one of the largest clinical studies in the field of<unk> . As a result of the GERAC<unk> , the<unk>  Federal Joint Committee ruled in April 2006 that the costs of<unk>  treatment for chronic back pain and knee osteoarthritis would be covered by public health insurers in<unk> y, though no coverage was offered for headache or migraine. However, because of the outcome of these<unk> , in the case of the other conditions, insurance corporations in<unk> y were not convinced that<unk>  had adequate benefits over usual care or sham treatments. No significant differences between<unk>  and sham<unk>  were found in any<unk>  However, the<unk>  also found that for chronic low back pain, the "effectiveness of<unk> , either verum or sham, was almost twice that of conventional therapy." According to Schweizer Fernsehen, the total cost of the<unk>  amounted to 7.5 million Euros. Several years after the committee's decision to incorporate<unk> l treatment into the healthcare of<unk> y was passed into law, the number of regular users of<unk>  in the country surpassed one million.
German acupuncture trials
Clinical trials on Ayurveda
Well-woman examination
Terre Haute prison experiments
Personal health application
Comparison of birth control methods
Blue boy trial
NHS treatments blacklist